Market & Pricing
Pricing changes, insurance coverage updates, Medicare negotiations, and market analysis for GLP-1 medications in 2026.
Pricing
Novo Nordisk Slashes Wegovy and Ozempic List Prices by Up to 50%
The Danish pharma giant announced its biggest-ever U.S. price reduction, bringing Wegovy to ~$675/month as competitive pressure intensifies.
Insurance
Medicare GLP-1 Coverage Goes Live: What 7 Million Seniors Need to Know
The Inflation Reduction Act's anti-obesity medication provision takes effect, covering semaglutide at $274/month for Medicare Part D enrollees.
Market Analysis
Oral GLP-1 at $149/Month Disrupts the Injectable Market
Eli Lilly priced Foundayo at $149/month—a fraction of injectable competitors. Wall Street reacted immediately.
Physician-Led Program · Lion MD
Compounded Semaglutide
Weekly injection. Appetite reduction + blood sugar regulation. Physician-monitored.
From $99/mo
Get Started →